EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

Morphea, Eosinophilic Fasciitis and Cancer: A Scoping Review

Maxine Joly-Chevrier, Alexa Gélinas, Stephanie Ghazal, Sarah Moussa iD, Catherine C McCuaig iD, Maryam Piram, Alexandra Mereniuk iD, Ivan V Litvinov iD, Mohammed Osman, Kevin Pehr, Elena Netchiporouk

Cancers · 07.09.2023 · 15 (18) · 4450

DOI: 10.3390/cancers15184450 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Cancers, online erschienen am 07.09.2023. Verfasst von Maxine Joly-Chevrier und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Université de Montréal, Montreal, QC H3T 1J4, Canada. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Morphea is an autoimmune fibrotic skin disease. Eosinophilic fasciitis (EF) is considered to belong to the severe spectrum of morphea. We conducted a scoping review assessing the risk of secondary cancer among morphea/EF patients, paraneoplastic morphea/EF and morphea/EF developing secondary to cancer therapy. The search was conducted using MEDLINE, Embase, Cochrane databases for articles published from inception to September 2022 following the Preferred Reporting Items for Systematic reviews and Meta-Analyses for Scoping Reviews (PRISMA-ScR) guidelines with no language or date restrictions. Two hundred and one studies were included. Of these, 32 studies reported on secondary cancer in morphea/EF patients, 45 on paraneoplastic morphea/EF and 125 on cancer-treatment-induced morphea/EF. While the current evidence remains limited, data suggest an increased risk of secondary cutaneous and possibly pancreatic malignancy in morphea patients, particularly the generalized subtype. There were insufficient data for EF. On the other hand, paraneoplastic morphea was anecdotal, whereas several observational studies suggested that ~10% of EF cases may be paraneoplastic, primarily in the context of hematologic malignancies. Radiotherapy-induced morphea is rare, seen in ~0.2% of treated patients and is usually localized to the treatment site, except in patients with pre-existing autoimmunity. While chemotherapy-induced cases are reported, immunotherapy morphea/EF cases are emerging and are preferentially seen with PD-1 and not CTLA-4 inhibitors. This study is limited by the type of articles included (case reports, case series and observational studies), and hence, additional research on this important topic is needed.

Schlagwörter

Stichwörter der Autor:innen

cancerchemotherapyeosinophilic fasciitisimmune checkpoint inhibitorsimmunotherapylocalized sclerodermamalignancymorpheaparaneoplasticradiation induced scleroderma

Autor:innen und Institutionen

  • Faculty of Medicine, Université de Montréal, Montreal, QC H3T 1J4, Canada.
  • Division of Dermatology, McGill University Health Centre, Montreal, QC H4A 3J1, Canada.
  • Faculty of Medicine, McGill University, Montreal, QC H3G 2M1, Canada.
  • Division of Pediatric Dermatology, Sainte-Justine Hospital, Montreal, QC H3T 1C5, Canada.
  • Division of Dermatology, Sacre Coeur Hospital, Montreal, QC H4J 1C5, Canada.
  • Division of Rheumatology, University of Alberta, Edmonton, AB T6G 2G3, Canada.

ORCID-Profile: Sarah Moussa, Catherine C McCuaig, Alexandra Mereniuk, Ivan V Litvinov

Zitieren

APA

Joly-Chevrier, M., Gélinas, A., Ghazal, S., Moussa, S., McCuaig, C. C., Piram, M., Mereniuk, A., Litvinov, I. V., Osman, M., Pehr, K., & Netchiporouk, E. (2023). Morphea, Eosinophilic Fasciitis and Cancer: A Scoping Review. Cancers, 15(18), 4450. https://doi.org/10.3390/cancers15184450

Vancouver

Joly-Chevrier M, Gélinas A, Ghazal S, Moussa S, McCuaig CC, Piram M, et al. Morphea, Eosinophilic Fasciitis and Cancer: A Scoping Review. Cancers. 2023;15(18):4450. doi:10.3390/cancers15184450

BibTeX
@article{JolyChevrier2023,
  author = {Joly-Chevrier, Maxine and Gélinas, Alexa and Ghazal, Stephanie and Moussa, Sarah and McCuaig, Catherine C and Piram, Maryam and Mereniuk, Alexandra and Litvinov, Ivan V and Osman, Mohammed and Pehr, Kevin and Netchiporouk, Elena},
  title = {Morphea, Eosinophilic Fasciitis and Cancer: A Scoping Review},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {18},
  pages = {4450},
  doi = {10.3390/cancers15184450}
}
Kostenlos starten →